The Therapeutic Goods Administration (TGA) of Australia has strengthened post-market surveillance measures for medical devices to better identify and manage safety issues, enabling swift responses whenever problems are detected. The key initiatives for monitoring adverse events related to medical devices include the following. 1) Medical device companies: Enhanced reporting mechanisms are being..

On June 16, 2025, the European Commission (EC) revised the Glossary of common ingredient names used in cosmetics labeling. This revision reflects the new ingredient names currently in use for cosmetics placed on the EU market. The key amendments are as follows.1) New INCI names, published by the Personal Care Product Council, have been adopted, and corrections have been made to existing ingredi..

The Therapeutic Goods Administration (TGA) charges fees for services such as product evaluations and activities involving Australian sponsors. In addition, an annual charge, which is a type of tax applied to the regulated industry, is imposed based on the financial year running from 1 July to 30 June each year. According to the Australian financial year, from 1 July 2025, the following annual c..

On June 19, 2025, the Ministry of Food and Drug Safety (MFDS) of Korea announced a partial amendment to the Enforcement Decree and Enforcement Rule of the Cosmetics Act. This amendment aims to establish matters delegated by the Act in relation to Cosmetics Day and the investigation of the current status of directly purchased foreign cosmetics. Following the amendment to the Cosmetics Act (effect..